Showing results (31-40 of 63) with videos related to
Sort By:
Pageof 7
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 24, 2005
Human-immunodeficiency-virus-negative, human-herpes-virus-8-negative abdominal cavity primary effusion lymphomaC Jenkins, Y Sorour, E Blake, et al.FEMS Microbiology Letters|January 1, 1990
A new fimbrial type (PCFO9) on enterotoxigenic Escherichia coli 09:H- LT+ isolated from a case of infant diarrhea in central AustraliaM W Heuzenroeder, T R Elliot, C J Thomas, et al.HIV Research & Clinical Practice|July 24, 2019
Pharmacokinetics (PK) of ethinylestradiol/levonorgestrel co-administered with atazanavir/cobicistatEmilie R Elliot, Elisa Bisdomini, Sujan Dilly Penchala, et al.The New Zealand Medical Journal|October 27, 1993
Bone mineral density in patients receiving suppressive doses of thyroxine for thyroid carcinomaC M Florkowski, B E Brownlie, J R Elliot, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|May 24, 2005
The precision of digital X-ray radiogrammetry compared with DXA in subjects with normal bone density or osteoporosisJohn R Elliot, Anna J Fenton, Tony Young, et al.Australian and New Zealand Journal of Medicine|October 1, 1993
Historical assessment of risk factors in screening for osteopenia in a normal Caucasian populationJ R Elliot, N L Gilchrist, J E Wells, et al.The New Zealand Medical Journal|February 23, 1994
Bone mineral density is reduced in female but not male subjects with Addison's diseaseC M Florkowski, S J Holmes, J R Elliot, et al.The New Zealand Medical Journal|September 8, 1993
Asymptomatic low bone mineral density in otherwise healthy people: four year follow upT J Wilkinson, J R Elliot, N L Gilchrist, et al.The Journal of Biological Chemistry|October 24, 2019
Structural and biophysical characterizations of HIV-1 matrix trimer binding to lipid nanodiscs shed light on virus assemblyR Elliot Murphy, Alexandra B Samal, Jiri Vlach, et al.Circulation|March 1, 1978
Failure of high doses of propranolol to reduce experimental myocardial ischemic damageT Peter, M K Heng, B N Singh, et al.Pageof 7